PAMU
SAGE

Pictet Asset Management (UK)’s Sage Therapeutics SAGE Stock Holding History

Pictet Asset Management (UK)’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$209K Sell
3,684
-316
-8% -$22.3K ﹤0.01% 1618
2021
Q1 		$299K Sell
4,000
-400
-9% -$32.8K ﹤0.01% 1445
2020
Q4 		$381K Hold
4,400
– – ﹤0.01% 1275
2020
Q3 		$269K Buy
+4,400
New +$223K ﹤0.01% 1279
2020
Q2 		– Sell
-77,056
Closed -$2.21M – 1201
2020
Q1 		$2.21M Sell
77,056
-262,642
-77% -$15.2M ﹤0.01% 836
2019
Q4 		$24.5M Buy
339,698
+101,763
+43% +$12.5M 0.04% 393
2019
Q3 		$33.4M Sell
237,935
-172,737
-42% -$28.9M 0.07% 303
2019
Q2 		$75.2M Sell
410,672
-33,900
-8% -$5.78M 0.16% 168
2019
Q1 		$70.7M Sell
444,572
-9,472
-2% -$1.37M 0.16% 187
2018
Q4 		$43.5K Buy
454,044
+62,496
+16% +$7.15M 0.11% 234
2018
Q3 		$55.3M Buy
391,548
+10,257
+3% +$1.58M 0.12% 232
2018
Q2 		$59.7M Sell
381,291
-8,188
-2% -$1.29M 0.14% 201
2018
Q1 		$62.7M Sell
389,479
-80,131
-17% -$13.6M 0.15% 191
2017
Q4 		$77.3M Buy
469,610
+90,565
+24% +$8.78M 0.2% 156
2017
Q3 		$23.6M Sell
379,045
-100,968
-21% -$7.93M 0.07% 334
2017
Q2 		$31.7M Buy
480,013
+52,124
+12% +$3.77M 0.1% 264
2017
Q1 		$30.4M Buy
427,889
+134,347
+46% +$7.87M 0.1% 263
2016
Q4 		$15M Sell
293,542
-49,887
-15% -$2.35M 0.06% 371
2016
Q3 		$15.8M Sell
343,429
-93,109
-21% -$3.79M 0.06% 357
2016
Q2 		$14.4M Buy
436,538
+395,238
+957% +$13.2M 0.06% 356
2016
Q1 		$1.21M Buy
+41,300
New +$1.45M 0.01% 743

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Pictet Asset Management (UK)'s SAGE Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Sage Therapeutics (SAGE) stake by 7.9% in Q2 2021, selling an estimated $22.3K and leaving 3,684 shares worth $209K. The position accounts for ﹤0.01% of the portfolio, ranked #1618.

Pictet Asset Management (UK) first reported a position in SAGE in Q1 2016 and has held it in 21 quarters since. The position peaked at $77.3M in Q4 2017. 256 funds tracked by Wall St. Rank hold SAGE as of Q2 2021.

  • Pictet Asset Management (UK) held 3,684 shares of Sage Therapeutics worth $209K as of Q2 2021.
  • Pictet Asset Management (UK) sold 316 Sage Therapeutics shares in Q2 2021, an estimated $22.3K.
  • Sage Therapeutics made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1618 holding.
  • Pictet Asset Management (UK) first reported a position in Sage Therapeutics in Q1 2016 and has held it in 21 quarters since.
  • Pictet Asset Management (UK)'s Sage Therapeutics position peaked at $77.3M in Q4 2017.
  • 256 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.